Antibody-Oligonucleotide Conjugates (AOCs) represent a new medical frontier which emerged through the integration of antibody technology with nucleic acid therapies. These hybrid molecules which integrate monoclonal antibodies precision with oligonucleotides gene-editing ability areRead More…